Glad you were diagnosed and treated quickly. For many people, chronic pain is not so easily diagnosed. This market is in the billiins of dollars annually. Medicare and physicians are in need of a better diagnostic tool for these tougher cases. MPDD fills that need and could become as common as a stethoscope in medical offices. Back pain alone is a $100 billion market. Then there's the migraine market, the neck pain market and sports medicine.
IMHO, EPGL is massively undervalued. Scoop all you can here at these levels while the opportunity is here. EPGL needs only to achieve 1% the success of Medtronic to be an 80 cent stock. Place your bets.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.